Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
CHART Trader
Monthly Subscription
for only
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Revance Therapeutics, Inc. RVNC NASDAQ Common Stock US7613301099
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  +0.05 +0.16% 31.25 31.55 31.25 31.4 31.2 09:42:58
more quote information »

Recent News

Date Time Source Heading
3/13/201816:43EDGARCurrent Report Filing (8-k)
3/13/201816:35EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
3/06/201816:05BWRevance to Participate in Upcoming Investor Conferences
3/02/201817:43EDGARSecurities Registration: Employee Benefit Plan (s-8)
3/02/201817:42EDGARAnnual Report (10-k)
2/28/201816:47EDGARCurrent Report Filing (8-k)
2/28/201816:13EDGARCurrent Report Filing (8-k)
2/28/201816:10BWRevance Releases Fourth Quarter and Full Year 2017 Results
2/28/201816:05PRNUSMylan to Bring a Biosimilar of BOTOX to the Market Through a..
2/22/201816:05BWRevance Therapeutics to Release Fourth Quarter and Full Year..
2/14/201816:05BWRevance to Participate in the RBC Capital Markets 2018..
2/09/201816:33EDGARCurrent Report Filing (8-k)
2/09/201809:39EDGARAmended Statement of Ownership (sc 13g/a)
2/08/201812:12EDGARSchedule 13g
2/07/201815:12EDGARAmended Statement of Ownership (sc 13g/a)
2/07/201815:04EDGARAmended Statement of Ownership (sc 13g/a)
2/01/201816:05BWPivotal SAKURA Phase 3 Clinical Data to be Presented at..
1/25/201814:11EDGARAmended Statement of Ownership (sc 13g/a)
1/23/201817:17EDGARAmended Statement of Ownership (sc 13g/a)
1/08/201816:23EDGARCurrent Report Filing (8-k)
1/08/201808:00BWRevance Announces Interim Phase 2a Results for RT002 in..
1/04/201808:49EDGARCurrent Report Filing (8-k)
1/04/201808:30BWRevance Provides Update on Anticipated Clinical Milestones..
12/11/201716:05BWRevance Announces Closing of Public Offering of Common Stock
12/07/201708:49EDGARCurrent Report Filing (8-k)
12/07/201708:46EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
12/07/201708:30BWRevance Announces Pricing of Public Offering of Common Stock
12/05/201717:30EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
12/05/201716:45BWRevance Announces Proposed Public Offering of Common Stock
12/05/201716:43EDGARAutomatic Shelf Registration Statement of Securities of..
12/05/201716:32EDGARCurrent Report Filing (8-k)
12/05/201707:37EDGARCurrent Report Filing (8-k)
12/05/201707:30BWRevance’s RT002 Meets Primary & All Secondary Endpoints,..
11/29/201716:05BWRevance Plans Phase 3 Program for RT002 Injectable to Treat..
11/24/201716:07EDGARStatement of Changes in Beneficial Ownership (4)
11/20/201716:05BWRevance Announces Orphan Drug Designation of RT002 for the..
11/03/201716:31EDGARQuarterly Report (10-q)
11/02/201716:22EDGARCurrent Report Filing (8-k)
11/02/201716:05BWRevance Releases Third Quarter 2017 Results
10/18/201716:05BWRevance Therapeutics to Release Third Quarter 2017 Financial..
10/18/201708:00BWRevance Completes Patient Enrollment in Phase 2 Program for..
9/19/201716:05BWRevance to Participate in the Cantor Fitzgerald 2017 Global..
9/06/201716:33EDGARCurrent Report Filing (8-k)
9/06/201707:30BWRevance Appoints Mark Foley to its Board of Directors
8/30/201716:05BWRevance to Participate in the 2017 Wells Fargo Securities..
8/25/201719:42EDGARStatement of Changes in Beneficial Ownership (4)
8/04/201717:10EDGARQuarterly Report (10-q)
8/03/201716:14EDGARCurrent Report Filing (8-k)
8/03/201716:05BWRevance Releases Second Quarter 2017 Results
8/02/201717:06EDGARCurrent Report Filing (8-k)
See more news about this stock »
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:40 V: D:20180320 13:58:03